Section 301 Tariffs: Updates & Resources
Section 232 Tariffs: Updates & Resources
Section 201 Tariffs: Updates & Resources
IEEPA Tariffs: Updates & Resources
General Tariff Resources
Tariff stacking chart & information on how companies can respond to tariff increases.
Internationally recognized trade compliance training.
March 31, 2026
2:00 PM ET - 3:00 PM ET
1 CCS / 1 CE Credit
Biopharma and life sciences companies face unique challenges when determining the country of origin for imports for research and development, clinical, and commercial cross-border transactions. These origin decisions must comply with U.S. customs laws for origin declaration for duty payments and origin marking, while also considering a myriad of other labeling concerns. This webinar provides an overview of basic U.S. customs law origin principles and highlights specific areas for review relevant to the industry.
Contact webinarorganizers@strtrade.com if you have issues registering. Please note we do not take American Express.
All attendees will receive a copy of the recording and presentation no later than 2 business days after the conclusion of the webinar.
Please note webinars are hosted by World Trade Interactive, Inc. Payments for our webinars will appear as World Trade Interactive, Inc. on your statement.
Military Veterans: Email webinarorganizers@strtrade.com to receive a discount. Thank you for your service!
ANDREA K. JEGLUM is an associate with Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. She also helps clients meet U.S. requirements concerning trade in biopharma, agro-chemicals, and animal products, including endangered species, as well as export filings and enforcement measures.
We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.